| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human EGF concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human EGF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human EGF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human EGF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human EGF. You can calculate the concentration of Human EGF in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 2.35 pg/mL |
|---|---|
| Detection Range | 3.91-250 pg/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human EGF in samples. No significant cross-reactivity or interference between Human EGF and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 2.35 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant EGF standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
One ternary nucleic acid delivery system with smart dextran-peptide coating enables in?vivo and ex?vivo wound therapy (2022) Matter. 10.1016/j.matt.2022.10.011
A radially aligned nanofiber scaffold with engineered guidance gradients for directed cell migration and accelerated wound healing (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123797
Transcriptome analysis of eutopic endometrial stromal cells in women with adenomyosis by RNA-sequencing (2022) Bioengineered. 10.1080/21655979.2022.2077614
EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression (2021) Cell Communication and Signaling. 10.1186/s12964-021-00783-2
Biological properties and characterization of several variations of a clinical human plasma-based skin substitute (HPSS) model and its manufacturing process (2024) Regenerative Biomaterials. 10.1093/rb/rbae115
Paper-Based Exosomal MicroRNA-21 Detection for Wound Monitoring: A Proof of Concept and Clinical Validation Trial Study (2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms24129822
Lipid Nanoparticles Enable Efficient EGF mRNA Delivery for Wound Healing (2026) Pharmaceutics. 10.3390/pharmaceutics18020215
A Cost-Effective, Multifunctional, Clinical-Oriented Double-Layer Electrospinning Membrane for Corneal Repair (2025) BIOMACROMOLECULES. 10.1021/acs.biomac.5c01311
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis (2025) Frontiers in Cell and Developmental Biology. 10.3389/fcell.2025.1518412
EGF-loaded, bioactive-rich Panax notoginseng-derived nanovesicles accelerate skin wound healing (2026) Frontiers in Cell and Developmental Biology. 10.3389/fcell.2026.1737435
Advanced platelet-rich fibrin promotes the paracrine function and proliferation of adipose-derived stem cells and contributes to micro-autologous fat transplantation by modulating HIF-1α and VEGF (2022) Annals of Translational Medicine. 10.21037/atm-21-6812
Preclinical evaluation on human platelet lysate for the treatment of secondary injury following intracerebral hemorrhage (2024) BRAIN RESEARCH BULLETIN. 10.1016/j.brainresbull.2024.111153
The therapeutic effect of sufficient oxygen-rich PRP injection in facial rejuvenation by multiple objective evaluations in 26 cases (2024) Regenerative Therapy. 10.1016/j.reth.2024.05.013
Long-term stability of frozen platelet-rich plasma under??80?°C storage condition (2024) Regenerative Therapy. 10.1016/j.reth.2024.09.006
Comparison of growth factor levels in injectable platelet-rich fibrin obtained from healthy individuals and patients with chronic periodontitis: a pilot study (2024) BMC Oral Health. 10.1186/s12903-024-04301-x
Investigation of EGF, IL1-α and IL-6 levels and selected hematological parameters (NLR, MPV) in patients with the chronic cholesteatomatous otitis media (2022) ACTA BIOCHIMICA POLONICA. 10.18388/abp.2020_6028
Galectin-3, IL-1A, IL-6, and EGF Levels in Corneal Epithelium of Patients With Recurrent Corneal Erosion Syndrome (2020) CORNEA. 10.1097/ICO.0000000000002422
